66
Views
0
CrossRef citations to date
0
Altmetric
Headache and Facial Pain

Safety of Rimegepant in Patients Using Preventive Migraine Medications: A Subgroup Analysis of a Long-Term, Open-Label Study Conducted in the United States

, &
Pages 1805-1814 | Received 08 Dec 2023, Accepted 05 May 2024, Published online: 23 May 2024

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.